Search results
Results from the WOW.Com Content Network
Testosterone is a medication and naturally occurring steroid hormone. [9] It is used to treat male hypogonadism, gender dysphoria, and certain types of breast cancer. [9] [10] It may also be used to increase athletic ability in the form of doping. [9]
But generally, men ages 30 to 45 with an ordinary risk of prediabetes may require screening at least every three years. It’s important to keep an eye on your blood sugar and take charge of your ...
Due to these diverse effects, there has been significant interest in developing long-lasting agonists of the GLP-1 receptor (GLP-1R) for the treatment of type 2 diabetes (T2D). GLP1R is also expressed in the brain [19] where it is involved in the control of appetite. [20] Furthermore, mice that over express GLP1R display improved memory and ...
After long-term androgen therapy, ovaries may develop polycystic ovary syndrome (PCOS) morphology, as both PCOS and transgender men there is an up-regulation of testosterone receptors in the ovaries. Untreated PCOS is associated with a possibly increased risk of endometrial cancer as well as decreased fertility.
Treatment decision support consists of the tools and processes used to enhance medical patients’ healthcare decision-making. The term differs from clinical decision support , in that clinical decision support tools are aimed at medical professionals, while treatment decision support tools empower the people who will receive the treatments.
Graded exercise therapy (GET) is a programme of physical activity that starts very slowly and gradually increases over time in fixed increments. Most public health bodies, including the CDC and NICE, consider it ineffective, and its safety is disputed. [35] [36] [37] In particular, NICE removed their recommendation for this treatment in 2021.
The Standards of Care for the Health of Transgender and Gender Diverse People (SOC) is an international clinical protocol by the World Professional Association for Transgender Health (WPATH) outlining the recommended assessment and treatment for transgender and gender-diverse individuals across the lifespan including social, hormonal, or surgical transition. [1]
Although a phase II trial for an injectable male contraceptive was halted in 2011 by an independent data safety monitoring board due likely to rare adverse effects experienced by some participants, [197] [67] leading many popular articles to suggest men could not tolerate side effects similar to those that many women endure on hormonal birth ...